Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
3
30%
Ph phase_2
7
70%

Phase Distribution

3

Early Stage

7

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
3(30.0%)
Phase 2Efficacy & side effects
7(70.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(6)

Detailed Status

unknown6
Completed2
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (30.0%)
Phase 27 (70.0%)

Trials by Status

unknown660%
withdrawn110%
completed220%
not_yet_recruiting110%

Recent Activity

0 active trials
Showing 5 of 10
not_yet_recruitingphase_1

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

NCT07444541
completedphase_1

An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast Cancer

NCT03505528
unknownphase_2

Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer

NCT03636308
unknownphase_2

Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer

NCT02124317
completedphase_1

Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients

NCT01336062
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07444541Phase 1

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Not Yet Recruiting
NCT03505528Phase 1

An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast Cancer

Completed
NCT03636308Phase 2

Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer

Unknown
NCT02124317Phase 2

Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer

Unknown
NCT01336062Phase 1

Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients

Completed
NCT02033538Phase 2

Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus

Withdrawn
NCT02135822Phase 2

Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic Cancer

Unknown
NCT01969955Phase 2

Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer

Unknown
NCT02016209Phase 2

Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer

Unknown
NCT01641783Phase 2

Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients

Unknown

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10